KUVAN Soluble tablet Ref.[9245] Active ingredients: Sapropterin

Source: European Medicines Agency (EU)  Revision Year: 2020  Publisher: BioMarin International Limited, Shanbally, Ringaskiddy, County Cork, Ireland

Product name and form

Kuvan 100 mg soluble tablets.

Pharmaceutical Form

Soluble tablet.

Off-white to light yellow soluble tablet with “177” imprinted on one face.

Qualitative and quantitative composition

Each soluble tablet contains 100 mg of sapropterin dihydrochloride (equivalent to 77 mg of sapropterin).

For the full list of excipients, see section 6.1.

Active Ingredient Description
Sapropterin

Sapropterin is a synthetic version of the naturally occurring 6R-BH4, which is a cofactor of the hydroxylases for phenylalanine, tyrosine and tryptophan. The rationale for administration of sapropterin in patients with BH4-responsive PKU is to enhance the activity of the defective phenylalanine hydroxylase and thereby increase or restore the oxidative metabolism of phenylalanine. The rationale for administration of sapropterin in patients with BH4 Deficiency is to replace the deficient levels of BH4, thereby restoring the activity of phenylalanine hydroxylase.

List of Excipients

Mannitol (E421)
Calcium hydrogen phosphate, anhydrous
Crospovidone type A
Ascorbic acid (E300)
Sodium stearyl fumarate
Riboflavin (E101)

Pack sizes and marketing

High-density polyethylene (HDPE) bottle with child-resistant closure. The bottles are sealed with an aluminium seal. Each bottle contains a small plastic tube of desiccant (silica gel).

Each bottle contains 30, 120 or 240 tablets.

1 bottle per carton.

Not all pack sizes may be marketed.

Marketing authorization holder

BioMarin International Limited, Shanbally, Ringaskiddy, County Cork, Ireland

Marketing authorization dates and numbers

EU/1/08/481/001
EU/1/08/481/002
EU/1/08/481/003

Date of the first authorisation: 02 December 2008
Date of latest renewal: 02 December 2013

Drugs

Drug Countries
KUVAN Austria, Australia, Brazil, Canada, Estonia, Spain, Finland, France, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Turkey, United Kingdom, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.